174 related articles for article (PubMed ID: 8982133)
41. Flow cytometric analysis of chimerism in the rat tolerant to a renal allograft.
Naar JD; Fisher RA; Saggi BH; Wakely PE; Tawes JW; Posner MP
J Surg Res; 1998 Jul; 77(2):179-86. PubMed ID: 9733606
[TBL] [Abstract][Full Text] [Related]
42. Bone formation in CaP-coated and noncoated titanium fiber mesh.
Vehof JW; van den Dolder J; de Ruijter JE; Spauwen PH; Jansen JA
J Biomed Mater Res A; 2003 Mar; 64(3):417-26. PubMed ID: 12579555
[TBL] [Abstract][Full Text] [Related]
43. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
45. [Experimental study of tissue engineered bone with coralline hydroxyapatite as scaffolds].
Shi PL; Gu XM; Chen FL
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Nov; 15(6):373-6. PubMed ID: 11762228
[TBL] [Abstract][Full Text] [Related]
46. Effect of hydroxyapatite coating crystallinity on dissolution and osseointegration in vivo.
Xue W; Liu X; Zheng X; Ding C
J Biomed Mater Res A; 2005 Sep; 74(4):553-61. PubMed ID: 16025491
[TBL] [Abstract][Full Text] [Related]
47. Growth of bone marrow cells on porous ceramics in vitro.
Uchida A; Nade S; McCartney E; Ching W
J Biomed Mater Res; 1987 Jan; 21(1):1-10. PubMed ID: 3558435
[TBL] [Abstract][Full Text] [Related]
48. Bone graft substitute using hydroxyapatite scaffold seeded with tissue engineered autologous osteoprogenitor cells in spinal fusion: early result in a sheep model.
Tan KK; Tan GH; Shamsul BS; Chua KH; Ng MH; Ruszymah BH; Aminuddin BS; Loqman MY
Med J Malaysia; 2005 Jul; 60 Suppl C():53-8. PubMed ID: 16381285
[TBL] [Abstract][Full Text] [Related]
49. Stimulation of osteogenic activity in mesenchymal stem cells by FK506.
Dai W; Dong J; Fang T; Uemura T
J Biomed Mater Res A; 2008 Jul; 86(1):235-43. PubMed ID: 18080300
[TBL] [Abstract][Full Text] [Related]
50. Comparative in vivo study of six hydroxyapatite-based bone graft substitutes.
Habibovic P; Kruyt MC; Juhl MV; Clyens S; Martinetti R; Dolcini L; Theilgaard N; van Blitterswijk CA
J Orthop Res; 2008 Oct; 26(10):1363-70. PubMed ID: 18404698
[TBL] [Abstract][Full Text] [Related]
51. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow.
Suzuki H; Patel N; Matthews M; DelRossi AJ; Doolin EJ; Hewitt CW
J Surg Res; 2000 Apr; 89(2):176-83. PubMed ID: 10729247
[TBL] [Abstract][Full Text] [Related]
52. Differential effects of bone graft substitutes on regeneration of bone marrow.
Schwartz Z; Doukarsky-Marx T; Nasatzky E; Goultschin J; Ranly DM; Greenspan DC; Sela J; Boyan BD
Clin Oral Implants Res; 2008 Dec; 19(12):1233-45. PubMed ID: 19040438
[TBL] [Abstract][Full Text] [Related]
53. [Porous hydroxylapatite ceramics with homologous osteoblasts from cell cultures for bone replacement].
Lang H; Mertens T
Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(1):64-8. PubMed ID: 1814669
[TBL] [Abstract][Full Text] [Related]
54. Osteogenesis in a rat model: use of bone marrow cells and biodegradable gelatin matrix carrier.
Troum S; Dalton ML
J South Orthop Assoc; 2001; 10(1):37-43. PubMed ID: 12132841
[TBL] [Abstract][Full Text] [Related]
55. Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: a comparison with the osteogenic ability of cancellous bone.
Yoshikawa T; Ohgushi H; Akahane M; Tamai S; Ichijima K
J Biomed Mater Res; 1998 Sep; 41(4):568-73. PubMed ID: 9697029
[TBL] [Abstract][Full Text] [Related]
56. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model.
Mitsuoka N; Iwagaki H; Ozaki M; Sheng SD; Sadamori H; Matsukawa H; Morimoto Y; Matsuoka J; Tanaka N; Yagi T
Transpl Immunol; 2004 Nov; 13(3):155-60. PubMed ID: 15381197
[TBL] [Abstract][Full Text] [Related]
57. Ectopic bone formation is enhanced in senescent animals implanted with embryonic cells.
Nimni ME; Bernick S; Ertl D; Nishimoto SK; Paule W; Strates BS; Villaneuva J
Clin Orthop Relat Res; 1988 Sep; (234):255-66. PubMed ID: 3044663
[TBL] [Abstract][Full Text] [Related]
58. Bone ingrowth into two porous ceramics with different pore sizes: an experimental study.
Galois L; Mainard D
Acta Orthop Belg; 2004 Dec; 70(6):598-603. PubMed ID: 15669463
[TBL] [Abstract][Full Text] [Related]
59. Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model.
Kriz J; Saudek F; Girman P; Novota P
Int J Tissue React; 2004; 26(3-4):75-83. PubMed ID: 15648439
[TBL] [Abstract][Full Text] [Related]
60. Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic.
Goshima J; Goldberg VM; Caplan AI
Biomaterials; 1991 Mar; 12(2):253-8. PubMed ID: 1878461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
